A new effort to prepare for future bird flu outbreaks is moving forward, despite a major funding setback. The American pharmaceutical and biotechnology company Moderna has initiated a large clinical ...

Moderna (MRNA) closed the most recent trading day at $55.60, moving +2.53% from the previous trading session. This change outpaced the S&P 500's 1.05% gain on the day. On the other hand, the Dow ...

Bird flu mRNA vaccine advances to Phase 3 testing with 4,000 participants. Discover how Moderna's H5N1 vaccine could ...

A UK-led bird flu vaccine trial has begun involving 4,000 volunteers as scientists prepare for the potential risk of a future ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Discover how arbovirus E Dimer vaccines are engineered to improve safety by minimizing antibody dependent enhancement.

A librarian as a test subject One survivor in ten after two years. That is the grim prognosis facing patients with pancreatic ...

Champions of Change Baton Rouge How Policy Really Gets Made Featuring Dr. Robert Malone & Noah Wall From scientific authority ...

Moderna has begun Phase 3 trials in the US and UK for its mRNA-based H5 bird flu vaccine, mRNA-1018, with funding from the Coalition for Epidemic Preparedness Innovations. The trial will test ...

Arbutus Biopharma Corporation (NASDAQ:ABUS) is one of the 10 Best Penny Stocks to Buy and Hold Under $5. On April 14, 2026, ...

Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

I Told You So! Scientists Who Were Ridiculed, Exiled, and Imprisoned for Being Right (St Martin’s Press) by Matt Kaplan ...